INTRODUCTION
The infection of hamsters with the vaccine strain of Venezuelan encephalitis virus (VEE), strain TC-83, is usually a self-limiting process (Austin & Scherer, I97I ; Jahrling & Scherer, I973 a, b, c) . The avirulent course of infection by the TC-83 strain depends in part on a host response which is inhibited by cyclophosphamide, since hamsters treated with this drug experience a high mortality rate following TC-83 virus inoculation (Jahrling, Dendy & Eddy, I974) . The virulence (or avirulence) of VEE viruses for hamsters probably depends on a balance between invasion of target tissues and interaction with host defence mechanisms. At least one virulent strain of VEE virus appears to be sensitive to an early host defence mechanism induced by TC-83 vaccine, since hamsters immunized I8 h prior to intraperitoneal challenge with the virulent Trinidad donkey strain of VEE virus were almost fully protected (Cole, Pedersen, & Robinson, I971) . Such early protection may depend on direct interference between vaccine and challenge viruses, or be mediated by interferon or specific factors. The virulence of VEE virus strains may be a function of the efficiency with which they induce these mechanisms or of their sensitivity to these mechanisms once induced. An understanding of the early protective mechanisms induced by TC-83 vaccine, and of the sensitivity of virulent VEE viruses to these mechanisms, may provide insight into the determinants for virulence of VEE viruses. P.B. JAHRLING
METHODS
Viruses and virus assays. The live attenuated VEE virus vaccine, strain TC-83, was obtained in the lyophilized state from Merrell-National Laboratories (lot 3, run 9). it was reconstituted with 1.2 ml of sterile water and passed once in primary chicken embryo cell cultures (CEC; Jahrling & Scherer, 1973a) . Virulent VEE virus, strain 68U2oi, was kindly provided by Dr William F. Scherer, Cornell University Medical College, New York. Strain 68U2oi was isolated from a sentinel hamster in Guatemala, and had been passed twice in suckling mouse brain before one additional pass in CEC. Vesicular stomatitis virus (VSV), Indiana strain, was obtained from the American Type Culture Collection (ATCC), and was passed once in CEC. All viruses were assayed by counting p.f.u, on CEC monolayers as described previously (Jahrling et al. 1974) .
Inoculation of hamsters and harvest of tissues. Male, golden Syrian hamsters (Lakeview Hamster Colony, Newfield, New Jersey) were used when they were 7 to 8 weeks old. Hamsters were inoculated subcutaneously (s.c.) over the back with o.2 ml of virus suspensions diluted in I ~ bovine albumin in Hanks' balanced salts solution at pH 8.o (BA]H). Virus concentrations as p.f.u, inoculated are stated in the tables. Heparinized plasma and organ suspensions for virus isolation were obtained from hamsters killed with chloroform using previously described procedures (Jahrling & Scherer, I973 c) . Tissues harvested for histopathological examination were fixed in neutral buffered formalin and stained with haematoxylin and eosin (H&E) using standard procedures.
Interferon assays. The HaK continuous cell line of hamster kidney cells was obtained from the ATCC at passage level IOI, and was used at passage level Io8. All interferon assays were performed in a single test. HaK ceils were seeded in Io cm 2 wells of plastic plates, and were used as confluent monolayers, 2 to 3 days later. Plasma samples were diluted I : Io in Eagle's minimal essential medium with Earle's salts (EMEM); bone marrow and spleen suspensions were not initially diluted. All samples were centrifuged at Iooooo g for 9o min to remove virus; supernatant fluids were exposed further to u.v. light for Io min. Serial twofold dilutions of samples were then made in EMEM containing 5 ~ heat-inactivated (at 56 °C for 3o min) foetal calf serum (FCS) and Gentamycin (lo units]ml). Medium was removed from the HaK cells, replaced with I ml of each sample dilution (2 wells]dilution) and incubated for I8 to 20 h at 37 °C in a humidified atmosphere containing 5 ~ CO2. After incubation, medium was aspirated from each well, and replaced with o.2 ml EMEM containing 8o to I2o p.f.u, of VSV, which was adsorbed for I h at 37 °C. After adsorption, each well was overlaid with z-o ml of medium containing I ~ agarose, basal medium (Eagle) with Earle's salts (pH 7"4), 4 ~ FCS, and Gentamycin. After incubation at 37 °C for 44 h, cells were further overlaid with I ml of a I : 75oo (w/v) dilution of neutral red, and plaques were counted after 4 h. The interferon endpoint was the dilution of tissue (w]v) expected to reduce the VSV challenge plaque count by 5o ~, as determined by probit analysis. The inhibitor present in two hamster plasma samples tested was further characterized as follows: the inhibitor was active after centrifuging at 1ooooo g for 9 o rain, and after exposure to n.y. light for Io min. Its activity was completely abolished by incubation with trypsin at a concentration of 2oo/zg/ml for 3 h at 37 °C, but was not affected by incubation with RNase (Ioo #g/ml) for 3 h at 37 °C, nor by dialysis for 48 h at pH 2.o. The inhibitor did not reduce the plaque count of VSV on LLCMK-z or CEC cells. Thus it conformed to generally accepted criteria for interferon (Lockart, I973) . The interferon levels obtained can be compared among themselves since they were assayed in a single test, but no hamster interferon standard was available for comparison. 
Interference in mixed VEE
Geometric mean titres based on tissues from 5 hamsters, _+ standard error of the mean. § The proportions of large to small (L to S) plaques are stated in the text; 15 ° to 200 plaques were measured for each specimen tested.
RESULTS
Hamsters were challenged with virulent VEE virus, strain 68U2oi, I2, 20 or 30 h after they had received TC-83 vaccine (Table I ). All hamsters challenged I2 h after TC-83 inoculation died with only slight prolongation of survival relative to non-vaccinated controls. A low, but significant degree of protection, and prolongation of survival was observed in the group challenged 2o h after vaccination. Of 20 hamsters which had received TC-83 vaccine 3o h prior to challenge only 2 died. To test the hypothesis that the vaccination of hamsters with TC-83 virus 20 or 30 h before challenge with virulent VEE virus, strain 68U2oi, resulted in a decreased replication of the challenge virus in target tissues, vaccinated and normal P.B. JAHRLING infected hamsters were sacrificed in groups of 5, at 24 and 48 h after 68U2oi challenge, and their tissues were assayed for infectivity ( Table 2 ). The presence of virulent virus in mixtures was initially detected on the basis of plaque morphology. (In probing experiments, virulent 68U2oi virus formed large plaques 7 to 8 mm in diam. on CEC monolayers, which differed from the small plaques of I to 2 mm formed by strain TC-83. Both virus strains were greater than 99 ~ homogeneous with respect to plaque morphology at the passage levels stated, and after re-isolation from plasma of hamsters inoculated s.c. In another study (Jahrling & Scherer, 1973 a) I oo small plaque clones of TC-83 virus were avirulent for hamsters. (Plaque isolates of large plaque 68U2o I virus have not been individually tested for hamster virulence.) The blood samples obtained 24 and 48 h after challenge from hamsters vaccinated 20 or 3o h before challenge contained both large and small plaques, indicating that the virulent 68U2oi challenge virus had replicated in both groups of vaccinated hamsters. However, the levels of virulent virus in the blood of challenged and TC-83 inoculated hamsters were much lower than in non-vaccinated 68U2oI-infected controls. The proportions of large to small plaques in blood from the 30 h group were approx. 8 : I, while for the 30 h group the proportions approached I : I. Assuming that all large plaques represented 68U2oi strain virus, and all small plaques TC-83 virus, the actual infectivities of each virus in mixed populations isolated from tissues were calculated. It was concluded that challenge infection with virulent virus did not interfere with the replication of the earlier TC-83 strain, while the replication of the challenge strain depended on the time since vaccination by strain TC-83.
In contrast to the finding of both large and small plaques in the blood of challenged hamsters, the virus isolated from spleens of both those in the 20 h and 30 h groups (Table 2) formed only small plaques. Likewise, bone marrows from 3o h group hamsters yielded only small plaques. (Between 150 and 200 plaques were measured for each specimen tested; therefore virus populations recorded as' only small plaque' were greater than 99 ~ homogeneous with respect to plaque morphology.) Unlike the uniformly small plaque virus isolated from the bone marrows of hamsters vaccinated 30 h before challenge, mixtures of large and small plaques were isolated from bone marrows of the 2o h group, in proportions for large to small plaques ranging from 3:1 to 6:1. Therefore, replication of virulent challenge virus in the bone marrow was significantly reduced in hamsters vaccinated 30 h, but not 20 h before challenge. In contrast, in spleen it was reduced for both groups.
Brain tissues were also tested for virus infectivity and plaque morphology. However, infectivities in brain were due largely to the blood they contained, since 24 and 48 h after inoculation they were I log10 (p.f.u./g) lower than blood, suggesting that virus did not replicate in the brain. For this reason, and because the brain is not a primary target in acute VEE virus infections in hamsters (Jahrling & Scherer, 1973 b) , the viruses in brain suspensions were not examined further.
To demonstrate more directly the presence or absence of virulent virus in the blood, spleen and bone marrow suspensions tested in Table 2 , a dilution of each suspension containing lO 4 p.f.u, was inoculated s.c. into 5 normal hamsters to test its virulence (Table 3) . Prior to this testing, however, it was necessary to determine the sensitivity of this method for detecting virulent virus in the presence of TC-83 vaccine. In the presence of IO 4 p.f.u. TC-83 vaccine, IOO p.f.u, of strain 68U2oi virus killed IO of IO hamsters, while IO p.f.u. killed only 9 of 15. Ten p.f.u, of 68U2oi alone killed IO of IO. At doses lower than IO p.f.u., strain 68U2oi did not uniformly infect or kill hamsters. On the basis of these data we concluded that mixtures of virus adjusted to contain IO 4 p.f.u, would kill most or all hamsters inoculated if at least I oo p.f.u, was contributed by strain 68U2o I virus (i.e., if the population of virus isolated was comprised of at least I ~ strain 68U2o I, it would kill hamsters). (88) 4 (16) 5 (20) * Each blood, spleen, and bone marrow suspension listed in Table 2 was diluted to contain 104 p.f.u./0.2 ml and was inoculated s.c. into 5 normal hamsters.
The results of virulence-testing the virus isolates confirmed that (I) virulent virus was present in the blood of groups of hamsters 24 and 48 h after challenge and that (2) virulent virus infectivities were greatly reduced in spleens of both groups and in the bone marrows of the 3o h but not the 2o h group.
The significant reduction of virulent virus replication in spleens, but not in bone marrows of hamsters vaccinated 20 h before challenge was further suggested by histopathological comparison of lesions in these tissues from two groups of five hamsters, vaccinated 2o h before challenge, and one group of five non-vaccinated, 68U2o~-infected hamsters. Bone marrows from the 20 h group, obtained when the hamsters were moribund 5 days after challenge, exhibited severe myeloid depletion and necrosis, similar to that observed in bone marrows of moribund 68U2oi control hamsters two days after inoculation. In contrast, spleens from moribund hamsters in the 2o h group were histologically normal, and contained none of the areas of severely necrotic white pulp, which developed in spleens of 68U2oI controls. Spleens obtained from hamsters in the 2o h group which were apparently healthy 3 days after challenge, were also histologically normal, thus reducing the possibility that a splenic lesion developed early and then regenerated in these hamsters.
Two possible mechanisms by which the virulent challenge virus replication was reduced in spleens and bone marrows of vaccinated hamsters may have involved direct virus interference between the vaccine and challenge viruses (e.g. competition for receptor sites) or may have been mediated by interferon. To explore these possibilities further, the concentrations of vaccine virus and interferon in the tissues of hamsters were determined 2o and 3o h after inoculation of TC-83 vaccine virus, i.e. at the time hamsters were challenged (Table 4) . interferon (IF) values at 3o h were much higher than at 2o h, in blood, spleen and bone marrow. From the calculations based on Table 2 , the infectivities of virulent challenge virus in spleens of hamsters vaccinated 2o h before challenge were reduced by greater than 2"4 and 3"I log10 (p.f.u./g) at 24 and 48 h after challenge respectively (Table 4 )-Twenty h after TC-83 vaccination, a mean of 2"7 log10 (IF units/g) of spleen were detected. In contrast, while the TC-83 vaccine virus infectivities in bone marrow were essentially the same as in spleen, IF was not detectable 2o h after vaccination, and virulent 68U2oi virus replication was not significantly reduced. By 3o h after TC-83 vaccination, IF was detectable in bone marrow, and challenge virus replication in bone marrow was correspondingly reduced by more than 3"~ log10 (p.f.u.). These data suggest that reduced challenge virus replication correlated more closely with interferon levels than with vaccine virus infectivities at the time of challenge. Tables 2 and 3. -t Calculated from Table 2 , and the observed proportions of large to small plaques. :~ Tissues which, from Tables 2 and 3 , would be expected to contain very low to undetectable levels of challenge virus.
DISCUSSION
Hamsters inoculated with the TC-83 vaccine strain of VEE virus were protected against a normally lethal challenge dose of virulent VEE virus, strain 68U2oi, inoculated 3o h after vaccination. Protection was correlated with the exclusion of virulent virus from spleen and bone marrow, previously reported to be important target tissues of virulent VEE virus strains in the hamster (Austin & Scherer, I97t; Jahrling & Scherer, 1973b, c) . The inhibition of virulent virus replication in bone marrow and spleen was correlated more closely with the interferon content of these organs at the time of challenge than with the infectious vaccine virus titres, implying that direct virus interference did not play a major role in restricting replication of the challenge virus. The present data do not, however, provide direct evidence that interferon is the sole mediator of protection, since the concentrations of other lymphokines undoubtedly fluctuate after TC-83 vaccination in parallel with interferon. Further indirect evidence that interferon performs a protective function in VEE virus-infected hamsters, is that hamsters inoculated with graded doses of poly I: poly C respond with graded concentrations of interferon in blood, spleen and bone marrow, and that these values can be correlated with inhibition of virulent VEE virus replication in these tissues as well as with protection (P. B. Jahrling, unpublished data). The present data suggest that the virulent VEE virus is sensitive to at least one early host defence mechanism induced by TC-83 vaccine, and imply that virulent virus is less efficient in the induction of this mechanism.
The defence mechanisms which become effective later and which terminate TC-83 viraemias in normal infected hamsters (Austin & Scherer, 1971) are apparently also effective ~against virulent VEE virus since the low but significant viraemia levels of challenge virus were eventually cleared from the blood of fully protected hamsters (vaccinated 30 h before challenge). Humoral antibody is probably a factor in this relatively late function. In the present study no attempt was made to determine if the virulent strain 68U2oi challenge virus induced an antibody response in TC-83-vaccinated hamsters since by conventional serological methods antibodies against strain 68U2oi cannot be distinguished in the presence of antibody against strain TC-83. However, Cole et aL (1972) reported that in hamsters vaccinated with TC-83 virus and challenged less than 24 h later with Eastern encephalitis virus (EEE) and Western encephalitis virus (WEE), antibody developed against only TC-83 vaccine. This was taken as evidence that the EEE and WEE challenge viruses did not replicate appreciably in TC-83-vaccinated hamsters. The replications of EEE and WEE viruses were not tested directly; it would be difficult using the methods employed for VEE virus reported here, since neither virus is readily distinguishable from TC-83 virus on the basis of plaque size, and relatively high titres of EEE or WEE virus are required to kill hamsters in the presence of IO 4 p.f.u, of TC-83 virus (unpublished observation). However, the failure of EEE and WEE virus to elicit an immune response in TC-83-vaccinated hamsters could have resulted from significantly decreased replication of these viruses in spleen although not necessarily in other tissues, such as bone marrow, analogous to the observation reported here for VEE viruses. Thus, vaccinated hamsters might become viraemic and survive an otherwise lethal VEE, WEE, or EEE virus challenge, and not develop an antibody response to the challenge virus.
The importance of the spleen in the early response of hamsters to TC-83 vaccination is inferred not only from early protection studies but from the observation that a large proportion of splenectomized hamsters died following TC-83 vaccine inoculation (Jahrling et al. 1974) . The mechanism by which splenectomy results in decreased resistance to TC-83 virus infection has not yet been defined.
The phenomenon of early protection of VEE virus-infected hamsters is similar to the early protection against VEE and EEE viruses induced by a different attenuated strain of VEE virus in mice (Hearn & Rainey, 1963) , and to the interference between the avirulent A7 strain of Semliki Forest virus (SFV) and a virulent VI3 strain in mice (Bradish, Allner & Maber, I971 , 1972; Bradish & Allner, 1972; Smillie, Pusztai & Smith, 1973) . In the SFV system, mice infected with A 7 showed limited replication in the target organ (brain) only after about 3 or 4 days. Replication in the spleen was efficient for both virulent and avirulent strains, but marginally more vigorous for the avirulent strains.
These early protection studies support the general concept that the virulence of a virus is not determined solely by its invasiveness or ability to grow in a target tissue; rather, that the expression of virulence depends on the composite interactions of virus both with target tissues and host defence mechanisms, and on the sensitivities of virus to those mechanisms once they are induced (Nathanson & Cole, I97O; Smith, I972; Stewart, I973) .
The present data indicate that virulent VEE virus is sensitive to at least one early host defence mechanism, which is induced more efficiently by TC-83 vaccine than by the virulent strain; that induction of this mechanism involves efficient interaction with the spleen and perhaps other lymphoid tissues, and that interferon is a likely effector of this early protective mechanism. The roles of other lymphokines (Lawrence, 1972) in this phenomenon remain to be investigated.
